| abstract |
The present invention relates to novel RAR selective retinoid agonists, pharmaceutically acceptable salts thereof, each isomer or racemic or non-racemic mixture thereof, wherein the symbols are as defined in the specification; To pharmaceutical compositions containing them, and to methods for using them as therapeutic agents:n n n (I)n n n . |